Inactive Instrument

Other languages Codiak BioSciences

Equities

CDAK

US1920101060

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Codiak BioSciences, Inc. Bankruptcy Case Dismissed	23-06-28
Motion for Case Dismissal Filed by Codiak BioSciences, Inc.	23-06-06
Motion for Joint Administration Approved for Codiak BioSciences, Inc.	23-03-29
Motion for Joint Administration Filed by Codiak BioSciences, Inc.	23-03-28
Sector Update: Health Care Stocks Higher in Afternoon Trading	23-03-27
Codiak BioSciences Files for Chapter 11 Bankruptcy, Plans to Sell Assets; Shares Plunge	23-03-27
Codiak BioSciences, Inc. Filed for Bankruptcy	23-03-27
Codiak BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03
Codiak Biosciences, Inc. Presents Preclinical Data Demonstrating Its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of Sars-Cov-2 and Related Sarbecoviruses	22-10-12
Sector Update: Health Care Stocks Tumble This Afternoon	22-09-13
Sector Update: Health Care	22-09-13
Codiak BioSciences Prices $20 Million Public Offering	22-09-13
Codiak BioSciences Plans Common Stock, Warrants Offering; Shares Plunge After Hours	22-09-12
Sector Update: Health Care Stocks Rebound Slightly in Late Trade, Pare Losses	22-08-30
Sector Update: Health Care	22-08-30
Codiak BioSciences to Cut Workforce by 37%; Explore Potential Partnerships to Extend Cash Runway	22-08-30
Codiak BioSciences, Inc Announces Reprioritization of its Clinical and Research Initiatives	22-08-30
Codiak BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04
Earnings Flash (CDAK) CODIAK BIOSCIENCES Reports Q2 Revenue $13.1M	22-08-04
Codiak Sees 'Platform-Validating' Data From Early Trials of Engineered Exosome Candidates	22-06-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Codiak BioSciences

Equities

CDAK

US1920101060

Other languages

Filters